Discover the top 8 companies transforming the proteomics market, including Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies, Inc., and other industry leaders. Backed by a market projected to grow from $33.63B to $65.80B by 2030 at a CAGR of 12.6%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights.

Download PDF Brochure:“Click Here”

Spotlights on the Industry’s Top Proteomics Companies

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific is a global leader in the proteomics market, providing an end-to-end ecosystem that integrates high-resolution mass spectrometry, automated sample preparation, and sophisticated bioinformatics software. The company’s flagship Orbitrap technology, including the recently unveiled Orbitrap Astral Zoom MS, sets the industry benchmark for deep, quantitative protein identification and high-throughput multiplexing. By combining these analytical capabilities with its Olink-powered high-plex assays and extensive laboratory consumables, Thermo Fisher supports the entire continuum of proteomics research from initial discovery and spatial analysis to clinical applications and precision oncology.

Danaher Corporation

Danaher Corporation operates as a premier life sciences and diagnostics innovator, leveraging a powerful portfolio of businesses including SCIEX and Cytiva to drive the proteomics workflow. Through SCIEX, the company delivers industry-leading mass spectrometry and capillary electrophoresis solutions, such as the ZenoTOF 7600, which are engineered for accurate protein characterization and rapid quantitation. Danaher’s ecosystem bridges the gap between research and practical application by integrating advanced bioprocessing tools with standardized, high-throughput analytical platforms, making it a critical partner for pharmaceutical and biotechnology companies focused on biomarker validation and the development of targeted therapeutics.

Agilent Technologies, Inc.

Agilent Technologies provides a comprehensive suite of bioanalytical instruments, consumables, and software designed to enable reproducible and sensitive proteomics workflows. The company distinguishes itself through its integrated liquid chromatography (LC) and mass spectrometry (LC-MS) systems, including triple-quadrupole and Q-TOF platforms, which are widely adopted for targeted protein quantification and clinical research. Agilent’s focus on digital lab optimization, supported by its CrossLab services and specialized cell analysis tools like Seahorse XF technology, ensures that laboratories can achieve high-quality results while improving operational efficiency and sustainability across multi-omics pipelines.

Bio-Rad Laboratories

Bio-Rad Laboratories is a prominent provider of life science research and clinical diagnostic products, offering essential tools for protein separation, purification, and analysis. The company’s portfolio includes a wide array of electrophoresis systems, chromatography resins, and multiplex immunoassay platforms that facilitate the study of protein expression and function. By focusing on reliable and scalable technologies, Bio-Rad supports researchers in academic and commercial settings as they investigate complex biological pathways and develop diagnostic assays for various disease states.

Revvity

Revvity is a specialized provider of health science solutions that focuses on accelerating the pace of discovery in proteomics and genomic medicine. The company offers integrated platforms for automated liquid handling, high-content imaging, and advanced detection reagents that enable the characterization of proteins within a cellular context. Revvity’s commitment to precision and innovation allows it to serve as a key partner for researchers looking to translate proteomic data into meaningful clinical outcomes, particularly in the fields of oncology and immunology.

Illumina Inc.

Illumina is a global leader in DNA sequencing and array-based technologies, increasingly expanding its influence into the proteomics space through high-throughput, NGS-based protein analysis solutions. By enabling the digital quantification of thousands of proteins simultaneously, Illumina facilitates a more holistic understanding of the relationship between the genome and the proteome. The company’s platforms are instrumental for large-scale cohort studies and multi-omics research, providing the scale and data depth necessary for advancing personalized medicine and discovering novel biomarkers.

Promega Corporation

Promega Corporation is a leading provider of innovative reagents and technologies for life science research, with a strong emphasis on tools for protein analysis and functional proteomics. The company’s portfolio includes advanced chemistries for bioluminescent protein detection, protein-protein interaction assays, and high-performance mass spectrometry sample preparation. Promega’s focus on developing sensitive and robust molecular tools enables scientists to interrogate complex biological systems with greater clarity, supporting drug discovery and basic research across the global scientific community.

Charles River Laboratories

Charles River Laboratories is a premier contract research organization (CRO) that provides essential drug discovery and development services, including comprehensive proteomic analysis. The company offers specialized expertise in protein characterization, biomarker identification, and bioanalytical testing to support the development of biologics and small-molecule therapies. By integrating advanced proteomic workflows into its broader preclinical and clinical service offerings, Charles River helps pharmaceutical and biotechnology clients accelerate their development timelines and gain deeper insights into drug efficacy and safety.

Download PDF Brochure:“Click Here”